한글목차

흡입 일산화질소 동향 및 전망

신생아 호흡기 치료, 천식 및 COPD, 급성 호흡곤란 증후군, 말라리아 치료, 결핵 치료 시장의 기회로 인해 세계 흡입 일산화질소 시장의 미래가 유망합니다. 세계 흡입 일산화질소 시장은 2024년부터 2030년까지 5.1%의 CAGR로 2030년까지 약 11억 달러에 달할 것으로 예상됩니다. 이 시장의 주요 촉진요인은 지속적인 연구 개발 활동과 함께 호흡기질환 및 기타 관련 질환의 유병률 증가입니다.

• Lucintel은 제품 유형별로는 소형 및 휴대형 전달 시스템의 도입으로 다양한 헬스케어 애플리케이션에서 일산화질소 요법을 쉽게 투여할 수 있게 됨에 따라 전달 시스템이 예측 기간 동안 높은 성장세를 보일 것으로 예상하고 있습니다.
• 이 용도 분류 중 천식 및 COPD는 천식 및 COPD 증상의 원인이 되는 담배 소비 증가로 인해 가장 높은 성장세를 보일 것으로 예상됩니다.
• 지역별로는 COPD 및 천식과 같은 질병의 급증, 고령화 인구의 증가, 그리고 이 지역의 주요 기업의 존재로 인해 북미가 예측 기간 동안 가장 높은 성장세를 보일 것으로 예상됩니다.

흡입 일산화질소 시장의 전략적 성장 기회

흡입형 일산화질소 시장은 다양한 응용 분야에서 전략적 성장 기회를 제공하고 있습니다. 주목할 만한 기회로는 기술 발전, 적응증에 대한 임상적 사용 증가, 효율적인 호흡 요법에 대한 수요 증가 등이 있습니다.

• 신흥 시장 진출 : 신흥 시장 진출은 고급 호흡 요법에 대한 수요 증가로 인한 성장 잠재력을 보여줍니다. 이들 지역은 흡입형 일산화질소 요법을 촉진하고 접근성을 향상시킬 수 있는 기회를 제공합니다.
• 첨단 전달 시스템 개발 : 새롭고 정밀하고 편안한 전달 시스템은 더 나은 치료 결과를 가져오고 더 많은 고객을 유치할 수 있습니다. 혁신적인 기술은 호황을 누리고 있는 흡입형 일산화질소 시장에서 경쟁 우위를 점할 수 있는 기회를 제공합니다.
• 새로운 임상 응용 분야 개척 : 폐 고혈압, 만성 호흡기질환 등 증상에 대한 흡입 일산화질소의 지리적 적용 확대는 성장 기회를 제공하고 치료의 가치를 높입니다.
• 원격진료와 연계된 치료를 위한 흡입형 일산화질소의 경제성 : 질산성 혈관확장제 광학장치와 선량 측정 도구를 결합하여 원격 환자 관리와 건강 데이터 수집을 가능하게 합니다. 이러한 통합은 치료의 질을 향상시키고 시장 성장을 지원할 수 있습니다.
• 비용 절감 기회 : 저렴한 가격의 일산화질소 흡입 시스템 개발은 자원이 부족한 지역의 호흡기 치료에 대한 수요를 충족시킬 수 있습니다. 보다 저렴한 제품은 시장 점유율을 확대하고 흡입형 일산화질소의 광범위한 사용을 촉진할 수 있습니다.

새로운 지역으로의 확장, 새로운 전달 장치 개발, 임상 적용 확대, 디지털 헬스 플랫폼과의 통합, 비용 효율적인 솔루션에 대한 집중은 전략적 성장 기회입니다. 이러한 노력은 시장 성장에 기여하고 흡입형 일산화질소 치료의 효능을 향상시킬 것으로 기대됩니다.

흡입 일산화질소 시장의 촉진요인 및 과제

흡입 일산화질소 시장은 주로 신기술, 규제 프레임워크의 변화, 사회 건강 상태의 변화 등의 영향을 받고 있습니다. 이러한 요인은 시장 성장을 촉진하고 흡입 일산화질소 요법의 채택 및 개발을 형성합니다.

흡입 일산화질소 시장을 주도하는 요인은 다음과 같습니다.

• 기술 개발 : 원격 측정 및 원격 환자 모니터링의 발전은 원격의료 솔루션을 더욱 효과적으로 만들고 흡입 일산화질소 요법을 이러한 시스템에 통합할 수 있게 합니다. 소비자가 새로운 장치를 제안하여 더 나은 의료 서비스를 제공 할 수 있습니다.
• 호흡기질환의 증가 : 호흡기질환의 이환율 증가는 흡입 일산화질소와 같은 효과적인 치료에 대한 수요를 증가시킬 것입니다. 이러한 추세는 경제적 지속가능성을 촉진하고 흡입 일산화질소 분야의 새로운 치료법과 기술 개발을 촉진할 수 있습니다.
• 규제 지원 : 지원적인 규제 프레임워크는 흡입용 일산화질소 시장에서 신제품 및 신기술 도입을 촉진합니다. 원활한 제품 승인과 기술 혁신의 매력은 시장 성장과 신제품 개발에 기여합니다.
• 의료 시설의 발전 : 특히 개발도상국의 의료 시설의 확장은 흡입 질소산화물 요법의 공급과 수용을 증가시킬 것입니다. 이는 의료 서비스 및 접근성 향상으로 인해 시장 성장에 긍정적인 영향을 미칠 것입니다.
• 신속하고 성공적인 치료의 중요성 : 조기 진단과 성공적인 치료는 흡입형 일산화질소와 같은 고급 치료법의 개발을 촉진합니다. 조기 개입은 환자의 결과를 개선하고 시장 성장을 지원합니다.

흡입 일산화질소 시장의 과제는 다음과 같습니다.

• 높은 비용 : 흡입형 일산화질소 기술의 비용은 특히 저소득 국가에서는 엄청난 비용으로 인해 보급을 제한하고 있습니다. 흡입형 일산화질소 요법에 대한 접근성을 확대하기 위해서는 비용 문제를 해결하는 것이 매우 중요합니다.
• 규제 장애물 : 규제 문제는 신제품의 발전과 시장 진입을 지연시킬 수 있습니다. 기업이 흡입용 일산화질소 시장에 새로운 기술을 도입하려면 이러한 장애물을 극복해야 합니다.
• 제한된 인식 및 교육 : 제한된 인식과 교육은 흡입 일산화질소 요법의 효과적인 투여에 영향을 미칠 수 있습니다. 흡입 일산화질소의 올바른 사용법에 대해 의료진을 교육하는 것은 환자의 결과를 개선하는 데 필수적입니다.

연구 활동, 호흡 곤란에 대한 새로운 장치 도입, 규제 활성화, 의료 시스템 개선, 예방 치료와 같은 시장 촉진요인이 흡입형 일산화질소 시장을 주도하고 있습니다. 시장은 또한 높은 비용, 규제 제한 및 인식 부족과 관련된 도전에 직면하고 있으며, 시장과 환자 치료를 지원하기 위해 이를 극복해야 합니다. 흡입형 일산화질소 요법을 확장하고 호흡기 치료에서 그 역할을 확대하기 위해서는 이러한 촉진요인과 도전 과제의 균형을 맞추는 것이 필수적입니다.

목차

제1장 주요 요약

제2장 세계의 흡입 일산화질소 시장 : 시장 역학

• 소개, 배경, 분류
• 공급망
• 업계 성장 촉진요인과 과제

제3장 2018년부터 2030년까지 시장 동향과 예측 분석

• 거시경제 동향(2018-2023년)과 예측(2024-2030년)
• 세계의 흡입 일산화질소 시장 동향(2018-2023년)과 예측(2024-2030년)
• 흡입 일산화질소 세계 시장 : 제품 유형별
  • 가스
  • 배송 시스템
• 흡입 일산화질소 세계 시장 : 용도별
  • 신생아 호흡기 치료
  • 천식과 COPD
  • 급성 호흡곤란증후군
  • 말라리아 치료
  • 결핵 치료
  • 기타

제4장 2018년부터 2030년까지 지역별 시장 동향과 예측 분석

• 지역별 흡입 일산화질소 세계 시장
• 북미의 흡입 일산화질소 시장
• 유럽의 흡입 일산화질소 시장
• 아시아태평양의 흡입 일산화질소 시장
• 기타 지역의 흡입 일산화질소 시장

제5장 경쟁 분석

• 제품 포트폴리오 분석
• 운영 통합
• Porter's Five Forces 분석

제6장 성장 기회와 전략 분석

• 성장 기회 분석
  • 제품 유형별 세계의 흡입 일산화질소 시장 성장 기회
  • 용도별 세계의 흡입 일산화질소 시장 성장 기회
  • 지역별 세계의 흡입 일산화질소 시장 성장 기회
• 세계의 흡입 일산화질소 시장 최신 동향
• 전략 분석
  • 신제품 개발
  • 세계의 흡입 일산화질소 시장 능력 확대
  • 세계의 흡입 일산화질소 시장 합병, 인수, 합작투자
  • 인증과 라이선싱

제7장 주요 기업 개요

• Air Liquide Healthcare
• BOC Healthcare
• Matheson Tri-Gas
• Merck
• Mallinckrodt Pharmaceuticals
• Nu-Med Plus
• Perma Pure

영문목차

Inhaled Nitric Oxide Trends and Forecast

The future of the global inhaled nitric oxide market looks promising with opportunities in neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, and tuberculosis treatment markets. The global inhaled nitric oxide market is expected to reach an estimated $1.1 billion by 2030 with a CAGR of 5.1% from 2024 to 2030. The major drivers for this market are the increasing prevalence of respiratory and other associated diseases along with ongoing research and development activities.

• Lucintel forecasts that, within the product type category, delivery systems are expected to witness higher growth over the forecast period due to the introduction of the compact and portable delivery system, which enables easier administration of nitric oxide therapy in various healthcare applications.
• Within this application category, asthma and COPD are expected to witness the highest growth due growing consumption of cigarettes, which contributes to asthma and COPD symptoms.
• In terms of regions, North America is expected to witness the highest growth over the forecast period due to the surging incidence of diseases like COPD and asthma, the increasing aging population, and the presence of major players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Inhaled Nitric Oxide Market

Inhaled nitric oxide is driving new developments and influencing the growth of the modality. These trends highlight advancements in technology, expanding applications, and increasing practices in healthcare.

• Improved Delivery Devices: New delivery systems allow for more accurate dosing and increased patient comfort. Device improvements also help maximize ileum activity, meaning the therapy could be integrated into neonatal and adult care by clinicians.
• Expanding Clinical Uses: The indications for inhaled nitric oxide treatment are expanding to ARDS, respiratory complications of COVID-19, and pulmonary hypertension. Research has shown that inhaled nitric oxide is effective in treating various respiratory illnesses.
• Synergy with Other Development Approaches: The use of conventional therapeutics such as mechanized respiratory support or pharmacological agents enhances inhaled nitric oxide therapy, playing a key role in patient management. This integrated approach improves therapy outcomes and helps manage more complex respiratory conditions.
• Focus on Cost-Effectiveness: While the benefits of inhaled nitric oxide therapy are gaining credibility, efforts are also being made to make delivery systems more affordable. Inexpensive solutions bring the therapy closer to patients, allowing a broader group to benefit from treatment.
• Advances in Research and Development: Ongoing research is advancing inhaled nitric oxide technology and broadening its use in medicine. With these efforts in R&D, it is reasonable to assume that other therapies are improving, including those where inhaled nitric oxide plays a role.

As demonstrated, emerging trends such as improved delivery mechanisms, wider clinical use, synergy with other therapies, emphasis on technological efficiency, and increased research activities are transforming the inhaled nitric oxide market. These trends are driving novel designs and improvements in treatments, expanding the scope of action, and enhancing the quality of patient care.

Recent Developments in the Inhaled Nitric Oxide Market

Recent trends in the inhaled nitric oxide market reflect advancements in technology, clinical applications, and patient treatment. These developments are shaping the industry's future in respiratory therapies.

• New Inhaled Nitric Oxide Delivery Systems: New delivery systems ensure careful administration of inhaled nitric oxide, improving patient outcomes. Advanced device technology has been shown to enhance the effectiveness and safety of inhaled nitric oxide, making it applicable in diverse clinical settings.
• Expanded Clinical Indications: Inhaled nitric oxide is used to improve outcomes in ARDS and acute SARS-CoV-2-induced respiratory failure. The extended use suggests that clinical evidence for improved therapeutic response has accumulated for a range of respiratory conditions.
• Cost-Effective Solutions: Affordable inhaled nitric oxide solutions improve accessibility, particularly in low-resource settings. These innovations encourage wider use of inhaled nitric oxide therapy, helping bridge gaps in respiratory care.
• Integration with Telemedicine: Telemedicine integration enables remote monitoring and management of inhaled nitric oxide therapy. This improves the quality of care by allowing necessary changes and communication throughout treatment.
• Increased Research and Clinical Trials: The growing number of research studies and clinical trials seeks to fully understand the benefits and uses of inhaled nitric oxide. These initiatives stimulate innovation and help create new treatment modalities and indications.

Recent developments such as new delivery systems, expanded clinical indications, cost-effective solutions, telemedicine integration, and increased research are significantly impacting the inhaled nitric oxide market. These factors enhance the efficiency, availability, and utilization of inhaled nitric oxide therapy.

Strategic Growth Opportunities for Inhaled Nitric Oxide Market

The inhaled nitric oxide market offers strategic growth opportunities in various applications. Notable opportunities include technological advancements, the growing clinical use of indications, and the rising need for efficient respiratory therapies.

• Expanding into Emerging Markets: Expanding into emerging markets presents growth potential due to the increasing demand for advanced respiratory therapies. These regions offer opportunities to promote inhaled nitric oxide therapy and improve accessibility.
• Developing Advanced Delivery Systems: New, precise, and comfortable delivery systems can lead to better treatment outcomes and attract more customers. Innovative technologies present opportunities for competitive advantage in the booming inhaled nitric oxide market.
• Exploring New Clinical Applications: Expanding the geographical use of inhaled nitric oxide for conditions such as pulmonary hypertension and chronic respiratory diseases offers growth opportunities and enhances the therapeutic value of the treatment.
• Economics of Inhaled Nitric Oxide for Remote and Connected Care: The use of nitro vasodilator optics combined with dosimetry tools allows remote patient management and health data capture. This integration improves care quality and supports market growth.
• Cost Reduction Opportunities: Developing affordable inhaled nitric oxide delivery systems responds to the demand for respiratory therapies in resource-limited regions. More affordable products increase market share and encourage wider use of inhaled nitric oxide.

Expanding to new geographies, developing new delivery devices, extending clinical applications, integrating with digital health platforms, and focusing on cost-effective solutions are strategic growth opportunities. These initiatives are expected to contribute to market growth and improve the effectiveness of inhaled nitric oxide therapy.

Inhaled Nitric Oxide Market Driver and Challenges

The inhaled nitric oxide market is influenced mainly by new technologies, changing regulatory frameworks, and shifts in societal health. These factors drive the market's growth and shape the adoption and development of inhaled nitric oxide therapies.

The factors responsible for driving the inhaled nitric oxide market include:

• Technological Developments: Advances in telemetry and remote patient monitoring make telehealth solutions more effective, enabling inhaled nitric oxide therapy to be integrated into such systems. Public feedback is also valuable, as consumers suggest new devices for improved delivery and better patient care.
• Increasing Respiratory Conditions: The rising incidence of respiratory conditions increases the demand for effective therapies like inhaled nitric oxide. This trend could drive economic sustainability and enhance the development of new treatments and technologies in the inhaled nitric oxide sector.
• Regulatory Support: Supportive regulatory frameworks facilitate the introduction of new products and technologies in the inhaled nitric oxide market. Smooth product approvals and attraction of innovation contribute to market growth and the development of new products.
• Development of Healthcare Facilities: The expansion of healthcare facilities, especially in developing regions, increases the supply and acceptance of inhaled nitric oxide therapy. This positively affects market growth by improving healthcare services and accessibility.
• Importance of Prompt and Successful Treatment: Early diagnosis and successful treatment drive the development of sophisticated therapies like inhaled nitric oxide. Early interventions improve patient outcomes, supporting market growth.

Challenges in the inhaled nitric oxide market are:

• High Costs: The cost of inhaled nitric oxide technology can be prohibitive, particularly for low-income countries, limiting its adoption. Addressing costs is crucial to expanding access to inhaled nitric oxide therapy.
• Regulatory Hurdles: Regulatory issues can slow the progress of new products and their market entry. Companies must overcome these hurdles to introduce new technologies in the inhaled nitric oxide market.
• Limited Awareness and Training: Limited awareness and training can affect the effective administration of inhaled nitric oxide therapy. Educating healthcare personnel on the correct use of inhaled nitric oxide is essential for better patient outcomes.

Drivers such as research activities, the introduction of new devices for respiratory difficulties, enabling regulation, healthcare system improvements, and preventive treatments are propelling the inhaled nitric oxide market. The market also faces challenges related to high costs, regulatory limitations, and a lack of awareness, which must be overcome to support the market and patient care. Achieving a balance between these drivers and challenges is essential for expanding inhaled nitric oxide therapy and broadening its role in respiratory medicine.

List of Inhaled Nitric Oxide Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies inhaled nitric oxide companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the inhaled nitric oxide companies profiled in this report include-

• Air Liquide Healthcare
• BOC Healthcare
• Matheson Tri-Gas
• Merck
• Mallinckrodt Pharmaceuticals
• Nu-Med Plus
• Perma Pure

Inhaled Nitric Oxide by Segment

The study includes a forecast for the global inhaled nitric oxide by product type, application, and region.

Inhaled Nitric Oxide Market by Product Type [Analysis by Value from 2018 to 2030]:

• Gas
• Delivery Systems

Inhaled Nitric Oxide Market by Application [Analysis by Value from 2018 to 2030]:

• Neonatal Respiratory Treatment
• Asthma and COPD
• Acute Respiratory Distress Syndrome
• Malaria Treatment
• Tuberculosis Treatment
• Others

Inhaled Nitric Oxide Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Inhaled Nitric Oxide Market

The corporate achievements in the inhaled nitric oxide market have been significant, particularly with the increase in technological advancements and understanding of its therapeutic value. Inhaled nitric oxide is primarily used to treat various respiratory disorders, enhancing oxygenation while minimizing pulmonary arterial pressure. As research and healthcare systems evolve, market trends are changing in countries like the United States, China, Germany, India, and Japan.

• United States: Recent improvements in the United States have not only focused on new formulations but also on advanced delivery systems. An important development has been FDA approvals for next-generation inhaled nitric oxide devices with improved safety and usability.
• China: In China, the inhaled nitric oxide segment has grown through the development of new treatment centers and the expansion of technology. Other trends include collaborations with international companies to introduce modern inhaled nitric oxide equipment in hospitals and research centers.
• Germany: Germany has introduced several innovations in the inhaled nitric oxide market, focusing on device safety and efficiency. Recent trends include the introduction of advanced delivery systems with better monitoring and ergonomics.
• India: The respiratory distress therapeutic market for inhaled nitric oxide is growing in India, with efforts to make this important therapy more accessible. Recent developments include the creation of affordable delivery systems, making treatment easier for individuals in both rural and urban areas.
• Japan: Japan has made strides in integrating inhaled nitric oxide into standard treatment protocols for respiratory diseases. Recent innovations include new devices with advanced features that enhance patient comfort.

Features of the Global Inhaled Nitric Oxide Market

Market Size Estimates: Inhaled nitric oxide market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Inhaled nitric oxide market size by product type, application, and region in terms of value ($B).

Regional Analysis: Inhaled nitric oxide market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, applications, and regions for the inhaled nitric oxide market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the inhaled nitric oxide market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the inhaled nitric oxide market by product type (gas and delivery systems), application (neonatal respiratory treatment, asthma and COPD, acute respiratory distress syndrome, malaria treatment, tuberculosis treatment, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Inhaled Nitric Oxide Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Inhaled Nitric Oxide Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Inhaled Nitric Oxide Market by Product Type
  • 3.3.1: Gas
  • 3.3.2: Delivery Systems
• 3.4: Global Inhaled Nitric Oxide Market by Application
  • 3.4.1: Neonatal Respiratory Treatment
  • 3.4.2: Asthma and COPD
  • 3.4.3: Acute Respiratory Distress Syndrome
  • 3.4.4: Malaria Treatment
  • 3.4.5: Tuberculosis Treatment
  • 3.4.6: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Inhaled Nitric Oxide Market by Region
• 4.2: North American Inhaled Nitric Oxide Market
  • 4.2.1: North American Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
  • 4.2.2: North American Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
• 4.3: European Inhaled Nitric Oxide Market
  • 4.3.1: European Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
  • 4.3.2: European Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
• 4.4: APAC Inhaled Nitric Oxide Market
  • 4.4.1: APAC Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
  • 4.4.2: APAC Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others
• 4.5: ROW Inhaled Nitric Oxide Market
  • 4.5.1: ROW Inhaled Nitric Oxide Market by Product Type: Gas and Delivery Systems
  • 4.5.2: ROW Inhaled Nitric Oxide Market by Application: Neonatal Respiratory Treatment, Asthma and COPD, Acute Respiratory Distress Syndrome, Malaria Treatment, Tuberculosis Treatment, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Application
  • 6.1.3: Growth Opportunities for the Global Inhaled Nitric Oxide Market by Region
• 6.2: Emerging Trends in the Global Inhaled Nitric Oxide Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Inhaled Nitric Oxide Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Inhaled Nitric Oxide Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Air Liquide Healthcare
• 7.2: BOC Healthcare
• 7.3: Matheson Tri-Gas
• 7.4: Merck
• 7.5: Mallinckrodt Pharmaceuticals
• 7.6: Nu-Med Plus
• 7.7: Perma Pure